The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Vitamin D status is associated with relapse rate in pediatric‐onset multiple sclerosis
Abstract
Objective: We sought to determine if vitamin D status, a risk factor for multiple sclerosis, is associated with the rate of subsequent clinical relapses in pediatric‐onset multiple sclerosis. Methods: This is a retrospective study of patients with pediatric‐onset multiple sclerosis or clinically isolated syndrome who were consecutively recruited into a prospective cohort at their clinical visit at the pediatric multiple sclerosis center of University of California, San Francisco or State University of New York at Stony Brook. Of 171 eligible patients, 134 (78%) with multiple sclerosis/clinically isolated syndrome were included in the cohort; a further 24 were excluded from this analysis due to lack of available serum (n = 7) or lack of follow‐up (n = 17). Serum 25‐hydroxyvitamin D 3 levels were measured and were adjusted to reflect a deseasonalized value. The adjusted serum 25‐hydroxyvitamin D 3 level was the primary predictor in a multivariate negative binomial regression model in which the main outcome measure was the number of subsequent relapses. Results: Among the 110 subjects, the mean unadjusted 25‐hydroxyvitamin D 3 level was 22 ± 9ng/ml. After adjustment for age, gender, race, ethnicity, disease duration, disease‐modifying therapy, and length of follow‐up, every 10ng/ml increase in the adjusted 25‐hydroxyvitamin D 3 level was associated with a 34% decrease in the rate of subsequent relapses (incidence rate ratio, 0.66; 95% confidence interval, 0.46–0.95; p = 0.024). Interpretation: Lower serum 25‐hydroxyvitamin D 3 levels are associated with a substantially increased subsequent relapse rate in pediatric‐onset multiple sclerosis or clinically isolated syndrome, providing rationale for a randomized controlled trial of vitamin D supplementation. ANN NEUROL 2010;67:618–624
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response
Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., et al. (2006) · Science · doi:10.1126/science.1123933 · Cited by 3,924
High Prevalence of Vitamin D Inadequacy and Implications for Health
Holick, M. F. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.3.353 · Cited by 2,005
Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study
Hyppönen, E., Läärä, E., Reunanen, A., Järvelin, M.-R., & Virtanen, S. M. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06580-1 · Cited by 1,928
Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2006) · JAMA · doi:10.1001/jama.296.23.2832 · Cited by 1,897
Prevention of Rickets and Vitamin D Deficiency in Infants, Children, and Adolescents
Wagner, C. L., Greer, F. R., & and the Section on Breastfeeding and Committee on Nutrition (2008) · Pediatrics · doi:10.1542/peds.2008-1862 · Cited by 1,613
Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol
Heaney, R. P., Davies, K. M., Chen, T. C., Holick, M. F., & Barger-Lux, M. J. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.1.204 · Cited by 1,396
Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation
Chen, S., Sims, G. P., Chen, X. X., Gu, Y. Y., Chen, S., & Lipsky, P. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1634 · Cited by 1,119
Consensus definitions proposed for pediatric multiple sclerosis and related disorders
Krupp, L. B., Banwell, B., & Tenembaum, S. (2007) · Neurology · doi:10.1212/01.wnl.0000259422.44235.a8 · Cited by 755
Self-citationComi, G., Filippi, M., & Wolinsky, J. S. (2001) · PubMed · Cited by 688
Comi, G., Filippi, M., Wolinsky, J. S., & European/Canadian Glatiramer Acetate Study Group (2001) · Annals of Neurology · doi:10.1002/ana.64 · Cited by 650
Immunomodulatory effects of Vitamin D in multiple sclerosis
Correale, J., Ysrraelit, M. C., & Gaitan, M. I. (2009) · Brain · doi:10.1093/brain/awp033 · Cited by 538
Ramagopalan, S. V., Maugeri, N. J., Handunnetthi, L., Lincoln, M. R., Orton, S.-M., Dyment, D. A., DeLuca, G. C., Herrera, B. M., Chao, M. J., Sadovnick, A. D., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000369 · Cited by 519
Gregori, S., Giarratana, N., Smiroldo, S., Uskokovic, M., & Adorini, L. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1367 · Cited by 483
Extra-renal 25-hydroxyvitamin D3-1α-hydroxylase in human health and disease
Hewison, M., Burke, F., Evans, K. N., Lammas, D. A., Sansom, D. M., Liu, P., Modlin, R. L., & Adams, J. S. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.12.078 · Cited by 394
Harris, S., & Dawson-Hughes, B. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.6.1232 · Cited by 346
Mapping Multiple Sclerosis Susceptibility to the HLA-DR Locus in African Americans
Oksenberg, J. R., Barcellos, L. F., Cree, B. A. C., Baranzini, S. E., Bugawan, T. L., Khan, O., Lincoln, R. R., Swerdlin, A., Mignot, E., Lin, L., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/380997 · Cited by 340
Self-citationAssociation of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis
Smolders, J., Menheere, P., Kessels, A., Damoiseaux, J., & Hupperts, R. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508094399 · Cited by 340
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis
Barcellos, L. F., Sawcer, S., Ramsay, P. P., Baranzini, S. E., Thomson, G., Briggs, F., Cree, B. C. A., Begovich, A. B., Villoslada, P., Montalban, X., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl223 · Cited by 317
Self-citationHLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course
Barcellos, L. F., Oksenberg, J. R., Begovich, A. B., Martin, E. R., Schmidt, S., Vittinghoff, E., Goodin, D. S., Pelletier, D., Lincoln, R. R., Bucher, P., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/367781 · Cited by 293
Self-citationVitamin D3 Confers Protection from Autoimmune Encephalomyelitis Only in Female Mice
Spach, K. M., & Hayes, C. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.4119 · Cited by 250
van der Mei, I. A. F., Ponsonby, A.-L., Engelsen, O., Pasco, J. A., McGrath, J. J., Eyles, D. W., Blizzard, L., Dwyer, T., Lucas, R., & Jones, G. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9937 · Cited by 238
Safety of vitamin D3 in adults with multiple sclerosis
Kimball, S. M., Ursell, M. R., O’Connor, P., & Vieth, R. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.645 · Cited by 227
Goldberg, P., Fleming, M. C., & Picard, E. H. (1986) · Medical Hypotheses · doi:10.1016/0306-9877(86)90010-1 · Cited by 200
Monthly Ambient Sunlight, Infections and Relapse Rates in Multiple Sclerosis
Tremlett, H. L., van der Mei, I. A. F., Pittas, F., Blizzard, L., Paley, G., Mesaros, D., Wood-Baker, R. R., Núñez, M., Dwyer, T., Taylor, B. V., et al. (2008) · Neuroepidemiology · doi:10.1159/000166602 · Cited by 184
Okuda, D. T., Srinivasan, R., Oksenberg, J. R., Goodin, D. S., Baranzini, S. E., Beheshtian, A., Waubant, E., Zamvil, S. S., Leppert, D., Qualley, P., et al. (2009) · Brain · doi:10.1093/brain/awn301 · Cited by 174
Self-citationWingerchuk, D. M. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.056499 · Cited by 170
Penna, G., Amuchastegui, S., Cossetti, C., Aquilano, F., Mariani, R., Sanvito, F., Doglioni, C., & Adorini, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8504 · Cited by 135
Lyakh, L. A., Sanford, M. E., Chekol, S., Young, H. A., & Roberts, A. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2061 · Cited by 120
Longitudinal changes in serum 25-hydroxyvitamin D in older people
Perry, H. M., Horowitz, M., Morley, J. E., Patrick, P., Vellas, B. J., Baumgartner, R., & Garry, P. J. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90201-9 · Cited by 103
Vitamin D Levels and Disease Status in Texas Patients With Systemic Lupus Erythematosus
Thudi, A., Su, Y., Wandstrat, A. E., Olsen, N. J., & Li, Q. (2008) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318134eeb6 · Cited by 92
Clinical predictors of early second event in patients with clinically isolated syndrome
Mowry, E. M., Pesic, M., Grimes, B. A., Deen, S. R., Bacchetti, P., & Waubant, E. L. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5063-0 · Cited by 85
Self-citationMelin, A. L., Wilske, J., Ringertz, H. G., & Sääf, M. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49236.x · Cited by 68
Cited by
Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy.
Ghasemi, N., Razavi, S., & Nikzad, E. (2016) · PubMed · doi:10.22074/cellj.2016.4867 · Cited by 685
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression
Ascherio, A., Munger, K. L., White, R., Köchert, K., Simon, K. C., Polman, C. H., Freedman, M. S., Hartung, H.-P., Miller, D. H., Montalbán, X., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5993 · Cited by 516
Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study
Mokry, L. E., Ross, S., Ahmad, O. S., Forgetta, V., Smith, G. D., Leong, A., Greenwood, C. M. T., Thanassoulis, G., & Richards, J. B. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001866 · Cited by 445
Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis
Simpson, S., Taylor, B., Blizzard, L., Ponsonby, A., Pittas, F., Tremlett, H., Dwyer, T., Gies, P., & van der Mei, I. (2010) · Annals of Neurology · doi:10.1002/ana.22043 · Cited by 457
Vitamin D and Multiple Sclerosis: A Comprehensive Review
Sintzel, M. B., Rametta, M., & Reder, A. T. (2018) · Neurology and Therapy · doi:10.1007/s40120-017-0086-4 · Cited by 435
Metadata
- Authors
- Mowry, E. M., Krupp, L. B., Milazzo, M., Chabas, D., Strober, J. B., Belman, A. L., McDonald, J. C., Oksenberg, J. R., Bacchetti, P., & Waubant, E.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2010-04-26
- Volume
- 67
- Issue
- 5
- Pages
- 618-624
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1606806706
- Cited by
- 329
- References
- 32
- FWCI
- 23.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.